135 related articles for article (PubMed ID: 25427001)
1. RABEX-5 is upregulated and plays an oncogenic role in gastric cancer development by activating the VEGF signaling pathway.
Wang S; Lu A; Chen X; Wei L; Ding J
PLoS One; 2014; 9(11):e113891. PubMed ID: 25427001
[TBL] [Abstract][Full Text] [Related]
2. RABEX-5 plays an oncogenic role in breast cancer by activating MMP-9 pathway.
Zhang X; Min J; Wang Y; Li Y; Li H; Liu Q; Liang X; Mu P; Li H
J Exp Clin Cancer Res; 2013 Aug; 32(1):52. PubMed ID: 23941575
[TBL] [Abstract][Full Text] [Related]
3. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
4. HOXC6 promotes gastric cancer cell invasion by upregulating the expression of MMP9.
Chen SW; Zhang Q; Xu ZF; Wang HP; Shi Y; Xu F; Zhang WJ; Wang P; Li Y
Mol Med Rep; 2016 Oct; 14(4):3261-8. PubMed ID: 27573865
[TBL] [Abstract][Full Text] [Related]
5. RON is associated with tumor progression via the inhibition of apoptosis and cell cycle arrest in human gastric cancer.
Song YA; Park YL; Kim KY; Myung E; Chung CY; Cho SB; Lee WS; Jung YD; Kweon SS; Joo YE
Pathol Int; 2012 Feb; 62(2):127-36. PubMed ID: 22243783
[TBL] [Abstract][Full Text] [Related]
6. VEGF promotes gastric cancer development by upregulating CRMP4.
Chen S; Zhang X; Peng J; Zhai E; He Y; Wu H; Chen C; Ma J; Wang Z; Cai S
Oncotarget; 2016 Mar; 7(13):17074-86. PubMed ID: 26934554
[TBL] [Abstract][Full Text] [Related]
7. Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.
Cheng YJ; Zhu ZX; Zhou JS; Hu ZQ; Zhang JP; Cai QP; Wang LH
World J Gastroenterol; 2015 Feb; 21(8):2323-35. PubMed ID: 25741138
[TBL] [Abstract][Full Text] [Related]
8. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferation effects of Twist gene silencing in gastric cancer SGC7901 cells.
Zhang H; Gong J; Kong D; Liu HY
World J Gastroenterol; 2015 Mar; 21(10):2926-36. PubMed ID: 25780290
[TBL] [Abstract][Full Text] [Related]
10. Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo.
Zhang L; Kim S; Ding W; Tong Y; Zhang X; Pan M; Chen S
Drug Des Devel Ther; 2015; 9():5579-90. PubMed ID: 26487802
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-32 increases human gastric cancer cell invasion associated with tumor progression and metastasis.
Tsai CY; Wang CS; Tsai MM; Chi HC; Cheng WL; Tseng YH; Chen CY; Lin CD; Wu JI; Wang LH; Lin KH
Clin Cancer Res; 2014 May; 20(9):2276-88. PubMed ID: 24602839
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo.
Zhang J; Kou YB; Zhu JS; Chen WX; Li S
Int J Oncol; 2014 Apr; 44(4):1268-76. PubMed ID: 24481712
[TBL] [Abstract][Full Text] [Related]
13. Methylation-silencing RCC1 expression is associated with tumorigenesis and depth of invasion in gastric cancer.
Lin YL; Chen HL; Cheng SB; Yeh DC; Huang CC; P'eng FK; Tsai TC; Wu CC; Chen CM
Int J Clin Exp Pathol; 2015; 8(11):14257-69. PubMed ID: 26823742
[TBL] [Abstract][Full Text] [Related]
14. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer.
Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH
Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338
[TBL] [Abstract][Full Text] [Related]
15. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation.
Zhao Y; Guo Q; Chen J; Hu J; Wang S; Sun Y
Oncol Rep; 2014 Jan; 31(1):358-64. PubMed ID: 24247585
[TBL] [Abstract][Full Text] [Related]
16. PDRG1 gene silencing contributes to inhibit the growth and induce apoptosis of gastric cancer cells.
Zhang YJ; Li JQ; Li HZ; Song H; Wei CS; Zhang SQ
Pathol Res Pract; 2019 Oct; 215(10):152567. PubMed ID: 31383535
[TBL] [Abstract][Full Text] [Related]
17. C/D-Box Snord105b Promotes Tumorigenesis in Gastric Cancer via ALDOA/C-Myc Pathway.
Zhang C; Zhao LM; Wu H; Tian G; Dai SL; Zhao RY; Shan BE
Cell Physiol Biochem; 2018; 45(6):2471-2482. PubMed ID: 29554660
[TBL] [Abstract][Full Text] [Related]
18. miR-338-3p suppresses gastric cancer progression through a PTEN-AKT axis by targeting P-REX2a.
Guo B; Liu L; Yao J; Ma R; Chang D; Li Z; Song T; Huang C
Mol Cancer Res; 2014 Mar; 12(3):313-21. PubMed ID: 24375644
[TBL] [Abstract][Full Text] [Related]
19. The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy.
Gou WF; Yang XF; Shen DF; Zhao S; Liu YP; Sun HZ; Takano Y; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19841-67. PubMed ID: 25904053
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of Slit2 promotes growth and motility in gastric cancer cells via activation of AKT/β-catenin.
Shi R; Yang Z; Liu W; Liu B; Xu Z; Zhang Z
Oncol Rep; 2014 Feb; 31(2):812-8. PubMed ID: 24297051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
